My primary investment is NWBO, I recommend it to all as potentially having explosive growth potential as it's vaccine which is made from the tumor while trialed in GBM should be effective in all solid tumors. They have applied for UK approval. I bring it up because like here, they have options and preferreds that add to over the 1.7 billion shares authorized, but the holders all seem to be working with the company. I expect that once they have approval and a much higher share price they will get more shares authorized, but it wouldn't surprise me if once revenue justifies it if they acquire the options and preferreds.
My point is, the high share count isn't a killer when the earning potential can be in double digit billions, or more. Firms like Apple and Tesla have billions of shares outstanding, it hasn't hurt them at all. If our technology ultimately ends up in the batteries of many of the different vehicle producers, I believe that we too have earning potential in the billions, if not double digit or better billions. One billion in earnings should support a market cap of $10 to $30 billion, IE a P/E of 10 to 30. If our O/S went to 2 billion, that's a $5 to $15 share price on a billion in earnings. Personally I would rather see that than a reverse split that could practically halve the market cap at the time if it goes the way of most reverse splits.
The really big news ought to deal with companies using our battery technology, as well as sales from the new acquisition, it shouldn't be about the fear of a reverse split. If the current holder of the company being acquired take preferred shares it won't even show as shares outstanding. As the company grows, if the holders of preferred shares need cash, they can certainly convert gradually and sell as they deem necessary to do so.
I'm new to the company, but I've seen how NWBO has worked for a few years and while they've yet to have serious money in the bank, they continue to operate on routinely selling some shares, and taking some loans. My point is, you can continue to operate this way until you have the success that an approval of their vaccine will bring. For us, a major contract to use our battery technology would provide the same sort of success.
Many here have much knowledge of the batteries, which I'm trusting, if our technology proves to be the basis for both current type batteries and future solid state batteries, I see no way that this company doesn't achieve at least a double digit billion dollar market cap, or be purchased for double digit billions or more.
Gary
Bullish
News 
Market Data 
Discover 
AI
